Product Highlight - Lixiana

• Proven efficacy vs warfarin^1-3
• Superior reduction in major bleeding vs warfarin^1-3
• Proven efficacy and safety in patients’ dose-reduced to 30 mg^1-3
• 24 hours anticoagulation^1,4
• Once daily with or without food^1,4
• Simple and convenient dosing across all indications^1-3

References:
1. LIXIANA^® Summary of Product Characteristics, May 2020.
2. Giugliano RP et al. N Engl J Med 2013;369(22):2093–104.
3. Giugliano RP et al. N Engl J Med 2013;369(22):Supplementary Appendix.
4. Bathala MS et al. Drug Metab Dispos 2012;40(12):2250-55.